Heather Cox - 01 Jun 2022 Form 4 Insider Report for HUMANA INC (HUM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Jun 2022, 10:32:53 UTC
Prior SEC filing
04 May 2022
Next SEC filing
03 Aug 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Heather Cox

Key filing fact

Heather Cox filed Form 4 for HUMANA INC (HUM) on 01 Jun 2022.

Key facts

  • This page summarizes Heather Cox's Form 4 filing for HUMANA INC (HUM).
  • 0 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 01 Jun 2022, 10:32.

Change

  • Previous filing in this sequence was filed on 04 May 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HUM holding

Humana Common

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,014
Date
01 Jun 2022
Ownership
Direct
HUM holding

Humana Common

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
380
Date
01 Jun 2022
Ownership
See Footnote
Footnotes
F10

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,155
Date
01 Jun 2022
Ownership
Direct
Underlying class
Humana Common
Underlying amount
10,155
Exercise price
$332.68
Footnotes
F1
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,388
Date
01 Jun 2022
Ownership
Direct
Underlying class
Humana Common
Underlying amount
5,388
Exercise price
$307.96
Footnotes
F2
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,372
Date
01 Jun 2022
Ownership
Direct
Underlying class
Humana Common
Underlying amount
5,372
Exercise price
$350.79
Footnotes
F3
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,057
Date
01 Jun 2022
Ownership
Direct
Underlying class
Humana Common
Underlying amount
4,057
Exercise price
$376.61
Footnotes
F4
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,877
Date
01 Jun 2022
Ownership
Direct
Underlying class
Humana Common
Underlying amount
2,877
Exercise price
$425.06
Footnotes
F5
HUM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
357
Date
01 Jun 2022
Ownership
Direct
Underlying class
Humana Common
Underlying amount
357
Exercise price
Footnotes
F6, F7
HUM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
658
Date
01 Jun 2022
Ownership
Direct
Underlying class
Humana Common
Underlying amount
658
Exercise price
Footnotes
F6, F8
HUM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
794
Date
01 Jun 2022
Ownership
Direct
Underlying class
Humana Common
Underlying amount
794
Exercise price
Footnotes
F6, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Heather Cox is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 10 footnotes

Footnote F1

Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive & Non-Qualified stock options granted to reporting person on 9/1/2018, vesting in three increments from 9/1/19 to 9/1/21.

Footnote F2

Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive & Non-Qualified stock options granted to reporting person on 2/25/2019, vesting in three increments from 2/25/20 to 2/25/22.

Footnote F3

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.

Footnote F4

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.

Footnote F5

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.

Footnote F6

Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

Footnote F7

Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

Footnote F8

Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

Footnote F9

Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

Footnote F10

Shares owned by spouse in an Individual Retirement Account.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .